This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Source: OpenUrl
Investigators from the Netherlands conducted a prospective observational study to assess immunogenicity of routine immunizations among preterm infants. Study participants were infants born at <36 weeks’ gestation enrolled at one of 8 Dutch hospitals between 2015 and 2017. Following the Dutch vaccination schedule, participants received a combination vaccine containing diphtheria and tetanus toxoids, acellular pertussis, inactivated poliomyelitis, Haemophilus influenzae type b (Hib), and hepatitis B (DTP-IPV-Hib-HBV; Infanrix-hexa, GlaxoSmithKline). It was administered at 6-9 weeks and 3 and 4 months of age as a primary series with a booster at 11 months of age, and a 10-valent pneumococcal conjugate vaccine (PCV10; Synflorix, GlaxoSmithKline) was administered at 6-9 weeks and 4 months as a primary series with a booster dose …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.